Cabaletta Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
– DesCAARTes™ trial progressing in cohort A5 with presentation of DSG3-CAART clinical and translational data from cohorts A3 and A4...
Day: March 17, 2022
Awakn Life Sciences Receives Regulatory Approval for Flagship Clinic in London to Begin Delivering Treatments
London Clinic Will Begin Delivering Ketamine-Assisted Therapy for Addiction & Mental HealthThird Location Adds to Two Existing Operatons in Bristol...
Connecticut Children’s First Children’s Hospital in State to Deploy Nym’s Coding Technology to Automate Medical Billing to Improve Patient Care Journeys
Nym’s Coding Engine Automates Revenue Cycle Management for Level 1 Pediatric Trauma Center, Bringing Greater Accuracy, Efficiency and Speed to...
Real Chemistry Reports 2021 Business Results
Transformational year highlighted by global revenue of $475 million and 36% growth SAN FRANCISCO--(BUSINESS WIRE)--Real Chemistry, a global health innovation...
PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System
First three patients underwent successful implantation and clinical utilization of PortIO as part of a first-in-human study in Colombia, South...
SphingoTec and Rivaara Labs Close Exclusive Distribution Agreement for Point of Care Diagnostics in India
The collaboration focuses on SphingoTec's near patient diagnostic solution for critical care settings.Rivaara gains exclusive rights to market and distribute...
AlzeCure Presents New Data at AD/PD Meeting on NeuroRestore’s Positive Effect on Mitochondrial Function
STOCKHOLM, SWEDEN / ACCESSWIRE / March 17, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical...
Promore Pharma has Reached Recruitment Goal in Clinical Trial of Ensereptide
STOCKHOLM, SWEDEN / ACCESSWIRE / March 17, 2022 / Promore Pharma (STO:PROMO) (FRA:8T0)STOCKHOLM, 17 March 2022 - Promore Pharma AB,...
5 Dosell are Implemented in a New Municipality
STOCKHOLM, SWEDEN / ACCESSWIRE / March 17, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group (publ.) hereby announces that the partner Zafe...
NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay in Non-Small Cell Lung Cancer
Study further highlights potential of RaDaR to stratify patients and improve treatment outcomesFT. MYERS, FL / ACCESSWIRE / March 17,...
Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Reports Final Data from Its Clinical Trial of Novel Nasal Spray, Sentinox, in SARS-CoV-2 Infected Patients
Despite Primary Endpoint not Being Met, Due to Small Sample Size, Results Show a Very Positive Trend in Efficacy Parameters...